PACB:NASDAQ
Pacific Biosciences of California Inc
$1.45
arrow_downward
-11.04%(-0.18) 1D
$1.43
arrow_downward
-1.19% (-0.017)bedtimeAfter hours
Closed: Jun 5, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PACB...
Open
$1.60
High
$1.62
Low
$1.39
Mkt. cap
450.37M
Avg. vol.
6.64M
Volume
6.48M
52-wk high
$2.73
52-wk low
$1.01
EPS
-$0.43
Beta
2.35
Shares outstanding
310.60M
No. of employees
485
Open
$1.60
High
$1.62
Low
$1.39
Mkt. cap
450.37M
Avg. vol.
6.64M
Volume
6.48M
52-wk high
$2.73
52-wk low
$1.01
EPS
-$0.43
Beta
2.35
Shares outstanding
310.60M
No. of employees
485
Analyst outlook
Analyst Ratings
Based on 4 analysts giving stock ratings to PACB in the past 3 months
Hold
Buy
2
Hold
1
Sell
1
12 month forecast
Based on 4 Wall Street analysts offering 12 month price targets for PACB in the last 3 months.
Highest
Current $1.45
$3.00 (+106.90%)
Average
$2.38 (+64.14%)
Lowest
$1.50 (+3.45%)
News stories
From sources across the web
Profile
Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing, based on the properties of zero-mode waveguides and sequencing by binding chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension. Wikipedia
About Pacific Biosciences of California Inc
CEOChristian Henry
Employees485
Founded2004
HeadquartersMenlo Park, California, United States
SectorHealth care
Websitepacb.com
AI content may include mistakes. Learn more